ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: It is now generally accepted that disease persistence is caused by primitive CML cells that are relatively insensitive to imatinib and other TKIs and can survive for prolonged periods of time despite complete BCR-ABL kinase inhibition.9,10